1. Home
  2. CHRS vs CLAR Comparison

CHRS vs CLAR Comparison

Compare CHRS & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • CLAR
  • Stock Information
  • Founded
  • CHRS 2010
  • CLAR 1957
  • Country
  • CHRS United States
  • CLAR United States
  • Employees
  • CHRS N/A
  • CLAR N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • CHRS Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • CHRS Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • CHRS 84.2M
  • CLAR 136.3M
  • IPO Year
  • CHRS 2014
  • CLAR N/A
  • Fundamental
  • Price
  • CHRS $0.90
  • CLAR $3.65
  • Analyst Decision
  • CHRS Buy
  • CLAR Strong Buy
  • Analyst Count
  • CHRS 3
  • CLAR 4
  • Target Price
  • CHRS $4.68
  • CLAR $5.50
  • AVG Volume (30 Days)
  • CHRS 1.2M
  • CLAR 194.3K
  • Earning Date
  • CHRS 08-07-2025
  • CLAR 07-31-2025
  • Dividend Yield
  • CHRS N/A
  • CLAR 2.77%
  • EPS Growth
  • CHRS N/A
  • CLAR N/A
  • EPS
  • CHRS N/A
  • CLAR N/A
  • Revenue
  • CHRS $272,251,000.00
  • CLAR $255,437,000.00
  • Revenue This Year
  • CHRS N/A
  • CLAR N/A
  • Revenue Next Year
  • CHRS $106.56
  • CLAR $4.23
  • P/E Ratio
  • CHRS N/A
  • CLAR N/A
  • Revenue Growth
  • CHRS 19.87
  • CLAR N/A
  • 52 Week Low
  • CHRS $0.66
  • CLAR $3.02
  • 52 Week High
  • CHRS $2.43
  • CLAR $6.55
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 59.04
  • CLAR 62.72
  • Support Level
  • CHRS $0.73
  • CLAR $3.52
  • Resistance Level
  • CHRS $0.82
  • CLAR $3.68
  • Average True Range (ATR)
  • CHRS 0.04
  • CLAR 0.11
  • MACD
  • CHRS 0.02
  • CLAR 0.00
  • Stochastic Oscillator
  • CHRS 88.02
  • CLAR 91.18

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: